Filter by: patients
Home > Community Treatment Reports and Side Effects > BG00012 Treatment Report
What is BG00012?

Two Phase III trials using BG00012: Efficacy and Safety of Oral BG00012 in Relapsing-Remitting Multiple Sclerosis (DEFINE) and Efficacy and Safety Study of Oral BG00012 With Active Reference in Relapsing-Remitting Multiple Sclerosis (CONFIRM)

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
MS (Multiple Sclerosis) 11 5 Efficacy_major Efficacy_moderate Efficacy_none
Participate in clinical trial 9 3 Efficacy_major Efficacy_slight
Other 2 0
Don't know 1 1 Efficacy_none

See all 14 patients currently taking BG00012

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
 0
Moderate
 2
Mild
 4
None
 2

Commonly reported side effects, conditions, and hospitalizations associated with BG00012

Stomach upset 5
Flushed 3
Headaches 3
Skin rash 1
Gas 1
Metallic taste in mouth 1
See all 10 reported side effects ▼ See top 6 reported side effects ▲

Reported Stop Reasons

Why Patients Stopped Taking BG00012 (multiple reasons could be selected)
Reason # Patients Percentage of patients
Other 2   Other: 50%
Course of treatment ended 2   Course of treatment ended: 50%
Did not seem to work 1   Did not seem to work: 25%

See all 4 patients who’ve stopped taking BG00012

Reported Duration See details about how long patients take this treatment ▼

Currently Taking BG00012

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0

Stopped Taking BG00012

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0

Reported Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Adherence of BG00012

Always
 7 88%
Usually
 0 0%
Sometimes
 1 13%
Never
 0 0%

Burden

Difficulty being on treatment

Burden of BG00012

Very
 0 0%
Somewhat
 0 0%
A little
 3 38%
Not at all
 5 63%

Cost

Paid out of pocket

Cost of BG00012

$200+
 0 0%
$100-199
 0 0%
$50-99
 0 0%
$25-49
 0 0%
< $25
 5 100%

Report created on May 28, 2012.